Purchase Order 36C25625P1366
Award Date
8/1/25
Potential Completion Date
11/30/25
Potential Value
$902K
Federal Agency
Veterans Integrated Service Network 16
Awardee
RLS (USA) Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Orleans, LA 70119, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $425,725.07 firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the supply of non-pet radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. It has a performance period from April 1, 2025 to March 31, 2026. The contract is not a set-aside. RLS (USA) Inc. is a small business that specializes in providing...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 5 (VISN 5), a component of the U.S. Department of Veterans Affairs (VA), to RLS (USA) Inc., a small business foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals, which are critical for nuclear medicine diagnostic services at VA medical centers. The contract has a ceiling value of $342,124.50 and a period of performance extending to March 31, 2026. RLS...
This is a $1,415,722.03 firm fixed price contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine operations at VA medical facilities. RLS USA Inc. has received numerous federal contracts from VA and the Defense Health Agency to supply medical isotopes such...
This is a federal contract award to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of radiopharmaceuticals and related supplies, with a ceiling value of $179,605.38 and a performance period through March 31, 2026. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and...
This is a firm-fixed price purchase order awarded to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7). The contract, valued at $440,764.00, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate to support nuclear medicine diagnostic services at VA medical centers. The award is designated as a total...
This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the provision of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The $833,285.36 firm fixed-price purchase order has a performance period ending on June 22, 2023. RLS (USA) Inc. is a small business that specializes in supplying critical molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear...
This is a $34,600.00 firm fixed-price purchase order contract awarded to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA). The contract is set aside for small businesses and has an ultimate completion date of October 24, 2024. RLS (USA) Inc. will provide the radiopharmaceutical drug ILLUCIX to support nuclear medicine diagnostic services at VA medical centers. This award is...
The U.S. Department of Veterans Affairs (VA) has awarded a firm-fixed price delivery order contract to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, for the supply of non-pet radiopharmaceuticals. The contract, valued at $232,388.97, has an ultimate completion date of March 31, 2025. RLS (USA) Inc. is a small business that specializes in providing a range of medical isotopes and radiopharmaceutical products to support nuclear medicine diagnostic services at VA medical centers...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to RLS (USA) Inc., a small business radiopharmacy company. The contract has a ceiling value of $159,704.34 and will run until February 28, 2026. RLS (USA) Inc. will provide radiopharmaceuticals, including specific isotopes such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and gallium-68 dotatate (NETSPOT), to...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract, valued at $1,395,620.34, is for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate to support nuclear medicine diagnostic services at VA medical centers. The contract is not set aside and was awarded on February 28, 2020, with...